Lp(a) is one of the most clinically meaningful — and most under-tested — cardiovascular risk factors in routine practice. Inaccurate assays, inconsistent reporting standards and disparities in testing across patient populations leave many at-risk patients undiagnosed and undertreated. This on-demand…
On Demand
Presented by:
Presenters:
- Howard S. Weintraub, MD, FACC, FAHA, FASPC, Clinical Professor of Medicine, NYU Grossman School of Medicine Clinical Director, NYU Center for the Prevention of Cardiovascular Disease
- Leslie J. Donato, Ph.D., D(ABCC), Co-Director Clinical Specialty Laboratory Co-Director Hospital Clinical Laboratory and Point of Care Associate Professor, Laboratory Medicine and Pathology Department of Laboratory Medicine and Pathology at Mayo Clinic
